Boston Scientific Announces Results For First Quarter 2017

Go back to Boston Scientific Announces Results For First Quarter 2017

Boston Scientific (BSX) PT Raised to $30 at Needham & Company

April 27, 2017 3:58 PM EDT

Needham & Company raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $29.00) while maintaining a Buy rating.

... More

Boston Scientific (BSX) PT Raised to $30 at Stifel

April 27, 2017 3:55 PM EDT

Stifel raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $28.00) while maintaining a Buy rating.

... More

Boston Scientific (BSX) PT Raised to $31 at Cowen

April 27, 2017 1:03 PM EDT

Cowen raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $29.00) while maintaining a Outperform rating amid "robust" top-line performance.

Analyst Joshua Jennings said the reason the company gave for the margin shortfall - non-recurring expenses- is "very plausible" and they... More

Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI; Revenue Beat was 'Remarkable'

April 27, 2017 12:00 PM EDT

Evercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating after the company "curshed" it on revenues for the quarter.

Analyst Vijay Kumar, "In large cap land, organic revenue beats of >400 bps... More